Schneider J R
Division of Cardiovascular and Thoracic Surgery, Evanston Hospital, IL 60201, USA.
Semin Vasc Surg. 1998 Mar;11(1):12-8.
Carotid endarterectomy for asymptomatic very-high-grade stenosis has been shown to be of clear benefit when compared with best medical treatment in recent prospective randomized studies. However, the benefit of carotid endarterectomy in these trials has been less than most vascular surgeons predicted based on prior nonrandomized studies. Furthermore, vascular surgeons often see patients who do not fit the inclusion criteria for any of the prospective randomized trials and whose potential benefit from endarterectomy may be different from that observed in those trials. Medical comorbidities or other patient characteristics that suggest even small increases in risk for carotid endarterectomy may negate the marginal benefit of the procedure in asymptomatic patients. Potential benefit is also highly dependent on surgeon-specific and hospital-specific perioperative morbidity and mortality. This article addresses some of the factors that may alter the potential benefit of carotid endarterectomy and the implications with respect to recommendations for or against carotid endarterectomy in the individual patient.
在最近的前瞻性随机研究中,与最佳药物治疗相比,颈动脉内膜切除术治疗无症状的极高等级狭窄已显示出明显益处。然而,在这些试验中,颈动脉内膜切除术的益处小于大多数血管外科医生根据先前的非随机研究所预测的。此外,血管外科医生经常会遇到不符合任何前瞻性随机试验纳入标准的患者,这些患者从内膜切除术中获得的潜在益处可能与那些试验中观察到的不同。提示颈动脉内膜切除术风险即使稍有增加的医学合并症或其他患者特征,可能会抵消该手术在无症状患者中的边际益处。潜在益处还高度依赖于外科医生和医院特定的围手术期发病率和死亡率。本文探讨了一些可能改变颈动脉内膜切除术潜在益处的因素,以及对个体患者进行颈动脉内膜切除术支持或反对建议的影响。